- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 22, 2026 | 192.38M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 200.17M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 162.57M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $438K |
| Capex | Q1 2026 · Mar 31, 2025 | $165K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$59.55M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$63.04M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $544.59M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $602.07M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $511.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $518.36M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $171.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $209.52M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $49.83M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $95.07M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $71.81M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $112.27M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $561.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $614.81M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $583.54M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $638.5M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.29 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $22.1M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $18.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $47.44M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $40.62M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$26.09M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$46.88M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$31.3M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$49.8M |
| Revenue | Q1 2026 · Mar 31, 2026 | $38.25M |
| Revenue | Q1 2026 · Mar 31, 2025 | $9.18M |